91 – 100 of 149
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Bedside point of care coagulation testing forindividualized antivitamin K reversal in emergencysurgery
2009) XXII Congress of the International Society of Thrombosis and Haemostasis In Journal of Thrombosis and Haemostasis 7(s2). p.1167-1167(
- Contribution to journal › Published meeting abstract
-
Mark
Can proteins induced by vitamin K absence - PIVKA-II - detect subclinical vitamin k deficit in major surgery?
2009) International Congress on Thrombosis and Hemostasis, 2009 In Journal of Thrombosis and Haemostasis 7(s2). p.404-404(
- Contribution to journal › Published meeting abstract
-
Mark
An evaluation of monitoring possibilities of argatroban using rotational thromboelastometry and aPTT
2009) International Congress on Thrombosis and Hemostasis, 2009 In Journal of Thrombosis and Haemostasis 7(s2). p.871-872(
- Contribution to journal › Published meeting abstract
- 2008
-
Mark
Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD)
(
- Contribution to journal › Article
-
Mark
Recombinant human factor VIIa and a factor VIIa-analogue reduces heparin and low molecular weight heparin (LMWH)-induced bleeding in rats
(
- Contribution to journal › Article
- 2007
-
Mark
Von Willebrand factor/factor VIII concentrate (Haemate(R) P) dosing based on pharmacokinetics: a prospective multicenter trial in elective surgery.
(
- Contribution to journal › Article
-
Mark
Treatment of severe von Willebrand disease with a high-purity von Willebrand factor concentrate (Wilfactin (R)): a prospective study of 50 patients
(
- Contribution to journal › Article
-
Mark
Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1VWD)
(
- Contribution to journal › Article
-
Mark
An immunochemical method for quantitative determination of latent antithrombin, the reactive center loop-inserted uncleaved form of antithrombin.
(
- Contribution to journal › Article
-
Mark
Systemic administration of anti-urokinase plasminogen activator receptor monoclonal antibodies induces hepatic fibrin deposition in tissue-type plasminogen activator deficient mice
(
- Contribution to journal › Article